APArmel Poda

Armel Poda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Armel Poda has a total of 83 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Patient Companions’ Knowledge and Practice of Infection Prevention and Control Measures in Health Facilities in the City of Bobo-Dioulasso, Burkina Faso

    by Arsene Hema, Santouro Arsène Somé, Odilon Kaboré, Soufiane Sanou, Armel Poda, Ziemlé Clément Meda, Abdoul Salam Ouedraogo, Léon Savadogo

    Healthcare in a hospital environment frequently involves patient companions who can serve as reservoirs and transmitters of infection. This study aimed to assess the knowledge and practices of patient companions regarding infection prevention and control (IPC) in healthcare settings of Bobo Dioulasso (Burkina Faso). A cross-sectional study including patient companions was conducted at Sourô Sanou University Hospital (CHUSS) and the Do and Dafra district hospitals. Multilevel linear regression model was employed to assess the associations between companion characteristics and their level of knowledge or practice. The statistical significance level was set at 5% for all analyses. A total of 789 patient companions were included. The average knowledge score on IPC was 32 out of 100. The average score for IPC practices in healthcare facilities was 81.0 out of 100. Male gender (P=0.029), urban residence (P=0.034), widower status (P=0.001), secondary education and above (P=0.000), and awareness (P=0.000) were found to be associated with a higher level of IPC knowledge. Secondary education and above (P=0.010), awareness (P=0.000), CHUSS and Do (P=0.012) were factors associated with good IPC practices. This results showed patient companions deficiency in IPC knowledge and practice. Main factors of this deficit were a paucity of education and insufficient awareness.

  • Open Access

    A Qualitative Study of the Experience of COVID-19 Patients in Burkina Faso

    by Blahima Konaté, Rachel Médah, Isidore Traoré, Samiratou Ouedraogo, Nongodo Firmin Kaboré, Ariane Kamga Mamguem, Oumar Billa, Dramane Kania, Hermann Badolo, Esperance Ouédraogo, et al.

    In Burkina Faso, the health system is characterized by systemic insufficient and antiquated health-care infrastructures. Consequently, few health-care establishments have the required resources to diagnose and manage patients with COVID-19, and fewer still have intensive care facilities for severely ill patients with COVID. Furthermore, there is a widespread scarcity of qualified health-care staff. The aim of this study was to explore the experiences of patients with COVID-19 who recovered after being cared for in Bobo Dioulasso and Ouagadougou. Using individual semistructured interviews, we performed a cross-sectional qualitative, descriptive study from June 12 to 30, 2020 with the aid of 13 well-educated patients who had survived COVID-19. The results reveal that prior to hospital admission, the main reason that prompted patients to seek care was onset of symptoms of COVID-19, regardless of whether they had been in contact with suspected or confirmed cases. Transmission was mainly believed to have occurred in the community, in the hospital, and during travel. Patient management was punctuated by frequent self-medication with medicinal plants or pharmaceutical drugs. The participants reported a negative perception of hospitalization or home-based management, with several forms of stigmatization, but a positive perception influenced by the satisfactory quality of management in health-care centers. This report of patient experiences could be helpful in improving the management of COVID-19 in Burkina Faso, both in the health-care setting and in home-based care.


  • Open Access

    Predictors of severe hypoxemia among COVID-19 patients in Burkina Faso (West Africa): Findings from hospital based cross-sectional study

    by Eric Arnaud Diendéré, Kongnimissom Apoline Sondo, Abdoul Risgou Ouédraogo, Désiré Lucien Dahourou, Kadari Cissé, Abdoulaye Sawadogo, Soumaila Maiga, Marcel Kuiré, Seidou Zida, Pierre R. Kaboré, et al.


  • Open Access

    Ten‐year attrition and antiretroviral therapy response among HIV‐positive adults: a sex‐based cohort analysis from eight West African countries

    by Thierry Tiendrebeogo, Eugène Messou, Shino Arikawa, Didier K Ekouevi, Aristophane Tanon, Vivian Kwaghe, Eric Balestre, Marcel Djimon Zannou, Armel Poda, François Dabis, et al.

    Introduction: Sex differences have already been reported in sub‐Saharan Africa for attrition and immunological response after antiretroviral therapy (ART) initiation, but follow‐up was usually limited to the first two to three years after ART initiation. We evaluated sex differences on the same outcomes in the 10 years following ART initiation in West African adults.Methods: We used cohort data of patients included in the IeDEA West Africa collaboration, who initiated ART between 2002 and 2014. We modelled no‐follow‐up and 10‐year attrition risks, and immunological response by sex using logistic regression analysis, survival analysis with random effect and linear mixed models respectively.Results: A total of 71,283 patients (65.8% women) contributed to 310,007 person‐years of follow‐up in 16 clinics in eight West African countries. The cumulative attrition incidence at 10‐year after ART initiation reached 75% and 68% for men and women respectively. Being male was associated with an increased risk of no follow‐up after starting ART (5.1% vs. 4.0%, adjusted Odds Ratio: 1.25 [95% CI: 1.15 to 1.35]) and of 10‐year attrition throughout the 10‐year period following ART initiation: adjusted Hazard Ratios were 1.22 [95% CI: 1.17 to 1.27], 1.08 [95% CI: 1.04 to 1.12] and 1.04 [95% CI: 1.01 to 1.08] during year 1, years 2 to 4 and 5 to 10 respectively. A better immunological response was achieved by women than men: monthly CD4 gain was 30.2 and 28.3 cells/mL in the first four months and 2.6 and 1.9 cells/μL thereafter. Ultimately, women reached the average threshold of 500 CD4 cells/μL in their sixth year of follow‐up, whereas men failed to reach it even at the end of the 10‐year follow‐up period. The proportion of patients reaching the threshold was much higher in women than in men after 10 years since ART initiation (65% vs. 44%).Conclusions: In West Africa, attrition is unacceptably high in both sexes. Men are more vulnerable than women on both attrition and immunological response to ART in the 10 years following ART initiation. Innovative tracing strategies that are sex‐adapted are needed for patients in care to monitor attrition, detect early high‐risk groups so that they can stay in care with a durably controlled infection.


  • Open Access

    Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting

    by Nongodo Firmin Kaboré, Armel Poda, Jacques Zoungrana, Ollo Da, Laura Ciaffi, Aoua Semdé, Issouf Yaméogo, Adrien B. Sawadogo, Eric Delaporte, Nicolas Meda, et al.

    It has been reported that people living with HIV in West Africa exhibited the highest risks for chronic kidney disease (CKD) in the world. Here, we aimed at determining the CKD frequency and changes in kidney function during antiretroviral treatment (ART) in a large cohort of HIV-patients followed in Burkina Faso. We included ART-naive adults who initiated ART at the Day Care Unit of the Souro Sanou University Hospital between 01/01/2007 and 12/31/2016. We assessed the estimated glomerular filtration rate (eGFR) by serum creatinine using the Modification of Diet in Renal Disease (MDRD) equation. Following the K/DOQI recommendations, CKD was defined as eGFR < 60 ml/min/1.73m2 at two consecutive measurements at least 3 months apart. The factors associated with eGFR decline or CKD were identified by mixed linear regression and Cox regression, respectively. Three thousand, one hundred and thirty-eight patients (72% women) were followed for a median (IQR) of 4.5(2.2–6.9) years. At baseline, median eGFR (IQR) was 110.7(94.4–128.4) ml/min/1.73m2 and 93 (3%) patients exhibited eGFR < 60 ml/min/1.73m2. The lowest-performing progressions of eGFR during the first year of ART were observed in patients with 40-49 yr. age range (− 8.3[− 11.7;-5.0] ml/min/1.73m2, p < 0.001), age ≥ 50 yr. (− 6.2[− 10.7;-1.8] ml/min/1.73m2, p = 0.006) and high blood pressure (HBP) (− 28.4[− 46.9;-9.9] ml/min/1.73m2, p = 0.003) at ART initiation. Regarding the ART exposure in patients with normal baseline eGFR, zidovudine (AZT) with protease inhibitor (PI) (− 4.7[− 7.7;-1.6] ml/min/1.73m2, p = 0.002), tenofovir (TDF) + PI (− 13.1[− 17.4;-8.7] ml/min/1.73m2, p < 0.001), TDF without PI (− 3.2[− 5.0;-1.4] ml/min/1.73m2, p < 0.001), stavudine (d4T) + PI (− 8.5[− 14.6–2.4] ml/min/1.73m2, p = 0.006) and d4T without PI (− 5.0[− 7.6–2.4] ml/min/1.73m2, p < 0.001) were associated with poorer eGFR progression. The prevalence of CKD was 0.5% and the incidence was 1.9 [1.3; 2.7] cases/1000 person-years. The risk of CKD was higher in patients with HBP (4.3[1.8;9.9], p = 0.001), 40-49 yr. patients (4.2[1.6;11.2], p = 0.004), ≥50 yr. patients (4.5[1.5;14.1], p = 0.009) and patients exposed to abacavir (ABC) or didanosine (ddI) based ART (13.1[4.0;42.9], p < 0.001). Our findings do not confirm the high risk of CKD reported in previous studies of West Africans with HIV, but support the recommendations for early initiation of ART and close kidney function monitoring in patients with HBP or aged ≥40 yr.


  • Open Access

    Knowing the Profile of Clients from the Screening and Information Centre (CADI) for Better Planning and Case Management in Bobo-Dioulasso, Burkina Faso

    by Poda A, Inã¨s DA, Traore I, Somda S, Hema A, Meda C, Sombie I, Traore M, Meda N

    Background: Counselling associated with screening is the entry point into the management for HIV-infected people. The purpose of the present study was to compare the profile of clients from the Screening and Information Centre (CADI) with those from the general population. Methods: A cross-sectional study including all complete medical records of CADI clients from 1996 to 2006 was conducted. The following information were collected: age, sex, education level, marital status, reasons for screening, desire to share one’s HIV status. The data were analyzed using stata13 software. Pearson khi2 Test was used to compare qualitative variables while Student Test was used to compare averages. The 0.05 significance level was applied. Results: A sample of 752 observations was analyzed. In 1996, the average age of CADI clients was (29.95 years [29.79 -31.26]) higher than the average age of the general population (21.7 years; p<0.0001). The proportion of women tested at CADI was similar to the proportion of the general population (p=0.980). The proportion of educated clients (73.03%) was higher than the general population (76.3%; p<0.0001), with the same applying for people living in couple (49.15%; p<0.0001) and workers (58.65%; p<0.0001). In 2006, the average age of people tested at CADI (30.62 years) was higher than the average age of the general population (21.7 years; p<0.0001). The proportion of women attending CADI (61.7%) was significantly higher than in the general population (51.7%; p<0.0001). The proportion of educated clients (75.56%) was also higher than the general population (26.1%; p<0.0001). The proportion of CADI clients living in couple was higher (58.93%) although it was low in the general population (0.6%; p<0.0001). Conclusion: The profile of CADI clients is different from the profile of the general population. Further action must therefore be taken for greater awareness among the less adhering to HIV screening.

  • Open Access

    Pregnancy rate and birth outcomes among women receiving antiretroviral therapy in Burkina Faso: a retrospective cohort study

    by Arsène Hema, Armel Poda, Aina Konaté, Firmin Kabore, Jacques Zoungrana, Euloges Kamboulé, Ibrahim Soré, Guillaume Bado, Abdoul-Salam Ouédraogo, Macaire Ouédraogo, et al.

    In Sub-Saharan Africa, few studies reported pregnancy incidence and outcomes in women taking antiretroviral therapy (ART). This survey aims to estimate the incidence and outcomes of pregnancy in a cohort of HIV positive women initiating ART in Bobo-Dioulasso, Burkina Faso. We carried out a retrospective cohort study. We selected women in childbearing age initiating ART and followed up in Bobo-Dioulasso teaching hospital between January 2005 and June 2011. The incidence of pregnancies during follow-up was calculated. Childbirth was defined by the expulsion of a fetus after 22 weeks of amenorrhea. Before this term, it is an abortion. Childbirth is said premature if it occurs before 37 weeks of gestation, to term if it occurs between the 38th and the 42nd week. The annual age-standardized fertility rates were calculated using the baseline population from the 2010 demographic and health survey (DHS) in Burkina Faso. A total of 1,763 women of childbearing age under ART were included in the study. They ranged between 18 and 48 years old with a median of 35 years old. A total of 222 pregnancies were observed during 4639 women-years of follow-up, corresponding to an incidence density of 5 pregnancies for 100 women-years (95% CI: 4.2-5.5). Among the 222 pregnancies recorded, 9(4.0%) ended with abortion, 205(92.4%) with childbirth (including 15 premature childbirths); the outcome of 8(3.6%) pregnancies were unknown abortion. Live birth and stillborn rates were 94.0% (193/205) and 6.0% respectively. The standard fertility rate in our cohort was 45 live births for 1,000 women-years. The general decrease in fertility rates was 66.0% among women infected with HIV compared to the overall population This study shows a low pregnancy incidence among women initiating ART as compared to their peers from the general population. Pregnancies that occurred during ART generally end with live births. Care packages for HIV infected women of childbearing age must include reproductive health services to better address this issue.